Max Healthcare Institute Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook

Max Healthcare Institute share price prediction 2027 comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 882.35 on NSE as of 9 October 2026, 27.8% below its 52-week high of Rs 1,221.90, after the company reported net profit of Rs 1,442.41 crore for FY26.

This Max Healthcare Institute stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.

Click Here – Get Free Investment Predictions

Max Healthcare Institute Share Price Today and Key Data

The Max Healthcare Institute share price today is Rs 882.35 on NSE, up 1.02% on the day. The market capitalisation stands at Rs 85,291 crore. Over the past year the price has fallen 23.7% from Rs 1,155.80. Every Max Healthcare Institute stock forecast figure below starts from this price.

Metric	Value
Company	Max Healthcare Institute (MAXHEALTH)
Current Price	Rs 882.35
52-Week High	Rs 1,221.90 (23 October 2025)
52-Week Low	Rs 870.00 (8 October 2026)
Market Cap	Rs 85,291 crore
PE Ratio	58.54
Industry PE	62.79
PB Ratio	7.94
EPS (TTM)	Rs 14.97
Return on Equity	13.42%
Debt to Equity	0.32
Dividend Yield	0.23%
Book Value per Share	Rs 110.39

What Is the Max Healthcare Institute Share Price Prediction for 2027?

The Max Healthcare Institute share price prediction for 2027 is a conservative case of Rs 1,015, a base case of Rs 1,059 and a bull case of Rs 1,183. Against Rs 882.35, these imply 15.0% upside, 20.0% upside and 34.1% upside. They are model scenarios built from reported EPS growth, not broker targets.

Scenario	EPS Growth Basis	EPS Estimate	PE Multiple	Implied Value	Upside vs Current Price
Conservative Case	Lower of FY26 growth (34.1%) and 4-year CAGR (24.0%) (capped at 15%)	Rs 17.22 (+15.0%)	Unchanged from today (price to EPS ratio kept constant)	Rs 1,015	+15.0%
Base Case	Average of the two (capped at 20%)	Rs 17.96 (+20.0%)	Unchanged from today (price to EPS ratio kept constant)	Rs 1,059	+20.0%
Bull Case	Higher of the two (capped at 25%)	Rs 18.71 (+25.0%)	Re-rated 7.3% toward industry PE of 62.79 (still at or below it)	Rs 1,183	+34.1%

Each target takes today's price of Rs 882.35 and scales it by the EPS growth assumed for that case, which is the same as holding the PE multiple constant. The conservative case uses the lower of the FY26 EPS growth and the 4-year EPS CAGR, the base case uses their average and the bull case uses the higher figure. The bull case also re-rates the PE multiple toward the industry level, because the stock trades below it. Together they form the Max Healthcare Institute target price range for the FY27 outlook over the next 12 months, and the range is not a point estimate.

Max Healthcare Institute Share Price Forecast: What Has to Go Right by 2027

Each Max Healthcare Institute target price below depends on a specific EPS outcome, and the text states that outcome next to the number.

Conservative Case for the Max Healthcare Institute Share Price Target: Rs 1,015

Reaching Rs 1,015 needs EPS to rise 15.0% to Rs 17.22 while the stock keeps its current PE multiple. That follows the slower 4-year EPS CAGR of 24.0%.

Base Case for the Max Healthcare Institute Share Price Target: Rs 1,059

Reaching Rs 1,059 needs EPS to rise 20.0% to Rs 17.96, the average of the FY26 growth rate and the 4-year CAGR. Net profit growth of 4.9% in Q1 FY27 is below that pace, so earnings need to speed up to reach this level.

Bull Case for the Max Healthcare Institute Share Price Target: Rs 1,183

Reaching Rs 1,183 needs EPS to rise 25.0% to Rs 18.71 and the PE multiple to re-rate 7.3% toward the industry PE. That sits inside the 52-week range of Rs 870.00 to Rs 1,221.90. A daily close above the nearest resistance level of Rs 995.10 (Supertrend) would be the first technical confirmation.

Max Healthcare Institute Financial Performance: Revenue, Profit and Margins

Max Healthcare Institute earned net profit of Rs 1,442.41 crore on revenue of Rs 8,536.07 crore in FY26, with profit up 34.1% and revenue up 18.8% compared with FY25. Diluted EPS was Rs 14.76 against Rs 11.01 a year earlier, and that earnings base anchors the Max Healthcare Institute share price forecast.

Year	Revenue (Rs Cr)	Net Profit (Rs Cr)	EPS (Rs)	Operating Margin	Net Margin
FY22	4,058.82	605.05	6.24	25.45%	14.91%
FY23	4,701.84	1,103.51	11.36	28.56%	23.47%
FY24	5,582.96	1,057.64	10.84	30.90%	18.94%
FY25	7,184.10	1,075.88	11.01	27.47%	14.98%
FY26	8,536.07	1,442.41	14.76	28.15%	16.90%

In the latest reported quarter, Q1 FY27 (quarter ended June 2026), revenue was Rs 2,406.69 crore against Rs 2,064.08 crore a year earlier (+16.6%), and the bottom line was a net profit of Rs 322.96 crore against a net profit of Rs 307.97 crore (+4.9%). Operating margin was 27.00% versus 27.59% in the year-ago quarter. Cash flow from operations was Rs 1,633.32 crore in FY26 against Rs 1,437.96 crore in FY25. Together these figures set the earnings base for the Max Healthcare Institute share price prediction.

Check the Univest Screener for live Max Healthcare Institute fundamentals

Is Max Healthcare Institute Overvalued or Undervalued Right Now?

Max Healthcare Institute trades at a PE of 58.54 against an industry PE of 62.79, which places the stock at a 6.8% discount to the industry average. The price-to-book ratio is 7.94 on a book value of Rs 110.39 per share. Return on equity of 13.42% means the company earns Rs 13.42 of profit for every Rs 100 of shareholder equity.

Debt to equity is 0.32, so borrowings equal about 32% of shareholder equity. The company declared a dividend of Rs 2.00 per share for FY26, a yield of 0.23% at the current price. This valuation context frames the Max Healthcare Institute stock price prediction for 2027 without relying on any outside forecast.

Max Healthcare Institute Stock Analysis: Technical Outlook

Max Healthcare Institute stock trades below its 50-day SMA of Rs 1,012.95 and below its 200-day EMA of Rs 1,041.69, and the combined daily indicators read bearish. The 52-week high of Rs 1,221.90 was set on 23 October 2025, while the 52-week low of Rs 870.00 came on 8 October 2026.

Indicator	Reading	Signal
RSI (14)	17.87	Oversold
MACD (12,26,9)	-37.06 vs signal -22.65	Bearish
ADX (14)	44.79	Established trend
Supertrend (10,3)	Price below Rs 995.10	Bearish
50-day SMA	Rs 1,012.95	Price below
200-day EMA	Rs 1,041.69	Price below

The nearest support level sits at Rs 870.00 (52-week low). The nearest resistance level sits at Rs 995.10 (Supertrend) and Rs 1,012.95 (50-day SMA). A sustained move above the nearest resistance would support the Max Healthcare Institute share price prediction 2027 base case, and this Max Healthcare Institute stock analysis uses daily candles only. Chart signals add context to the Max Healthcare Institute share price target without changing the earnings maths.

Max Healthcare Institute Shareholding Pattern

Promoters hold 23.71% of Max Healthcare Institute as of Jun 2026, down from 23.74% in Jun 2025 across the last 5 quarters. FII holding is 41.78% (down from 54.76% in Jun 2025) and DII holding is 29.96% (up from 17.42% in Jun 2025), which puts combined institutional holding at 71.74%. Public shareholders own 4.56%. Shareholding data is one input for any Max Healthcare Institute stock forecast.

Key Risks to the Max Healthcare Institute Share Price Target for 2027

Earnings and Margin Risk

Operating margin has ranged from 25.45% to 30.90% between FY22 and FY26, so a slip toward the lower end would trim the EPS estimate behind the Max Healthcare Institute stock forecast. Revenue was up 18.8% in FY26, and slower revenue growth would weigh on the profit path.

Size and Liquidity Risk

Market capitalisation stands at Rs 85,291 crore. Investors should check daily traded volumes and order book depth on NSE before sizing a position, because price moves can be sharper when volumes thin out. Liquidity is a practical constraint on any Max Healthcare Institute stock price target.

Balance Sheet Risk

Debt to equity of 0.32 means borrowings stand at about 32% of shareholder equity. A rise in borrowing costs or a jump in debt would weigh on profit and on the multiple behind the Max Healthcare Institute share price forecast.

Technical Risk

The daily indicators read bearish, so the targets above may need a technical turn before the price follows earnings. A daily close below Rs 870.00 (52-week low) would weaken the setup further.

Conclusion

This Max Healthcare Institute stock analysis puts the share price target range for 2027 at Rs 1,015 to Rs 1,183, with a base case of Rs 1,059 against Rs 882.35 today. The inputs are a PE of 58.54 that sits at a 6.8% discount to the industry average, EPS growth of 34.1% in FY26 and a daily technical setup that reads bearish. The next quarterly result will show which scenario is gaining ground. This analysis is educational, so consult a SEBI-registered advisor before acting on it.

Download the Univest iOS App or Univest Android App to track Max Healthcare Institute live price and get daily stock recommendations.

Frequently Asked Questions on Max Healthcare Institute Share Price Prediction 2027

What is the Max Healthcare Institute share price target for 2027?

Ans. The Max Healthcare Institute share price forecast for 2027 has a conservative case of Rs 1,015, a base case of Rs 1,059 and a bull case of Rs 1,183. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.

What is the Max Healthcare Institute share price today?

Ans. Max Healthcare Institute trades at Rs 882.35 on NSE as of 9 October 2026, up 1.02% on the day. The 52-week range is Rs 870.00 to Rs 1,221.90.

Is Max Healthcare Institute a good stock to buy for 2027?

Ans. The data points in different directions: the PE of 58.54 is at a 6.8% discount to the industry average, EPS grew 34.1% in FY26 and the daily technical setup reads bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.

Can Max Healthcare Institute stock reach Rs 1,183 in 2027?

Ans. Reaching Rs 1,183 needs EPS to rise 25.0% from Rs 14.97 and the PE multiple to re-rate toward the industry PE of 62.79, plus a daily close above Rs 995.10 (Supertrend). This is a scenario, not a guarantee.

What are the support and resistance levels for Max Healthcare Institute?

Ans. The nearest support levels are Rs 870.00 (52-week low), and the nearest resistance levels are Rs 995.10 (Supertrend) and Rs 1,012.95 (50-day SMA).

What are the main risks for Max Healthcare Institute stock in 2027?

Ans. The main risks to the Max Healthcare Institute share price forecast are a fall in operating margin from the 25.45% to 30.90% range seen since FY22, slower revenue growth after FY26 revenue was up 18.8%, and thin trading volumes. Debt to equity of 0.32 adds balance sheet sensitivity.

How is the Max Healthcare Institute target price for 2027 calculated?

Ans. Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 15.0% growth, the base case 20.0% and the bull case 25.0%, all drawn from the company's reported FY26 and 4-year EPS growth.